Isoprenaline hydrochloride | | | 99.86% |
Norepinephrine | α1-adrenergic receptor α2-adrenergic receptor | Beta-1 adrenergic receptor | 99.43% |
Propranolol hydrochloride | | | 99.96% |
Zenidolol hydrochloride | | | 99.74% |
Phenylephrine | | | 99.98% |
Arformoterol | | Beta-2 adrenergic receptor, Kd: 2.9 nM | 99.96% |
CL 316243 | | | 99.98% |
Propranolol | | | 99.87% |
D-Mannitol | | Beta-3 adrenergic receptor | 99.93% |
Phenylephrine hydrochloride | | | 99.97% |
Norepinephrine hydrochloride | α1-adrenergic receptor α2-adrenergic receptor | Beta-1 adrenergic receptor | 99.95% |
Metoprolol | | | 99.97% |
Atenolol | | Beta-1 adrenergic receptor, Ki: 697 nM | 98.85% |
Clozapine | α2-adrenergic receptor, Ki: 51 nM (Inhibitor) | | 99.84% |
Dexmedetomidine | α2-adrenergic receptor, Ki: 1.08 nM | | 99.93% |
Prazosin hydrochloride | | | 99.51% |
Dexmedetomidine hydrochloride | α2-adrenergic receptor, IC50: 1.08 nM | | 99.94% |
Salbutamol | | | 99.53% |
Nadolol | | | 99.94% |
Norepinephrine bitartrate monohydrate | α1-adrenergic receptor α2-adrenergic receptor | Beta-1 adrenergic receptor | 99.96% |
Phenylacetylglycine | | | 99.63% |
Mirabegron | | | 99.90% |
(S)-Timolol maleate | | | 99.89% |
Salmeterol | | β2 adrenoceptor, pEC50: 9.6 β1 adrenoceptor, pEC50: 6.1 β3 adrenoceptor, pEC50: 5.9 | 99.91% |
Labetalol | | | 99.94% |
Dobutamine hydrochloride | | | 99.91% |
SR59230A | | | ≥98.0% |
L748337 | | Beta-3 adrenergic receptor, Ki: 4 nM Beta-2 adrenergic receptor, Ki: 204 nM Beta-1 adrenergic receptor, Ki: 390 nM | 99.67% |
Vilanterol trifenatate | | | 99.61% |
Guanfacine hydrochloride | | | 99.93% |
Atipamezole | | | 99.84% |
Tamsulosin | | | 99.77% |
Phentolamine | | | 99.94% |
Clonidine hydrochloride | | | 99.96% |
Bisoprolol hemifumarate | | Beta-1 adrenergic receptor | 99.84% |
Brimonidine tartrate | | | 99.57% |
Octopamine hydrochloride | | | 99.90% |
Paliperidone | | | 99.43% |
SR59230A hydrochloride | | | 99.87% |
Mirtazapine | α2-adrenergic receptor, pKi: 6.95 | | 99.94% |
Acebutolol hydrochloride | | | 99.63% |
Indacaterol maleate | | | 99.82% |
Fenoterol | | | 99.08% |
Atipamezole hydrochloride | | | 99.97% |
Indacaterol | | | 99.98% |
Bufuralol | | | 99.17% |
Vibegron | | β3 adrenoceptor, EC50: 1.1 nM | 98.26% |
Terazosin hydrochloride | | | 99.72% |
Butaxamine hydrochloride | | Beta-2 adrenergic receptor | 99.87% |
Medetomidine hydrochloride | α2-adrenergic receptor, Ki: 1.08 nM α1-adrenergic receptor, Ki: 1750 nM | | 99.80% |
Metoprolol succinate | | | 99.56% |
Pronethalol | | | 99.73% |
Blonanserin | α2-adrenergic receptor, Ki: 530 (Rat c nM α1-adrenergic receptor, Ki: 26.7 (Rat nM | | 99.62% |
Piribedil | | | 99.33% |
Vilanterol | | | 99.30% |
Nefazodone hydrochloride | | | 99.87% |
Phentolamine mesylate | | | 99.87% |
Terazosin hydrochloride dihydrate | | | 99.93% |
Doxazosin mesylate | | | 98.34% |
Terbutaline | | Beta-2 adrenergic receptor | 99.77% |
Reboxetine mesylate | | | 99.90% |
Fenoterol hydrobromide | | | 99.90% |
Ecopipam hydrochloride | Alpha-2A adrenergic receptor, Ki: 731 nM | | 99.46% |
DL-Norepinephrine hydrochloride | | | 99.59% |
Carazolol | | β1 adrenoceptor β2 adrenoceptor β3 adrenoceptor | 99.71% |
Terbutaline sulfate | | | 99.95% |
Harmane | α2-adrenergic receptor, IC50: 18 μM | | 99.91% |
JP1302 dihydrochloride | human α2C-adrenoceptor, Ki: 28±2 nM human α2B-adrenoceptor, Ki: 1470±130 nM human α2A-adrenoceptor, Ki: 3150±50 nM rodent α2D-adrenoceptor, Ki: 1700±200 nM | | 99.62% |
Brimonidine | | | 99.99% |
Olodaterol | | β2 adrenoceptor, EC50: 0.1 nM | 98.47% |
Naftopidil | Alpha-1A adrenergic receptor, Ki: 3.7 nM Alpha-1B adrenergic receptor, Ki: 20 nM Alpha-1D adrenergic receptor, Ki: 1.2 nM | | 98.47% |
Nicergoline | | | 99.06% |
Metoprolol tartrate | | | 99.98% |
Lubabegron | | | 98.21% |
Methyldopa | | | 98.25% |
Methyldopa hydrate | | | 99.95% |
Talipexole dihydrochloride | α2-adrenergic receptor, IC50: 25 nM | | 99.80% |
Alfuzosin | | | 99.96% |
(S)-(-)-Propranolol hydrochloride | | | 99.95% |
LY 344864 | rat α1-adrenergic receptor, Ki: 5.06 μM rat α2-adrenergic receptor, Ki: 3.69 μM | | 98.93% |
Oxprenolol hydrochloride | | β-adrenoceptor, Ki: 7.1 nM | 99.86% |
Salmeterol xinafoate | | β2 adrenoceptor, pEC50: 9.6 β1 adrenoceptor, pEC50: 6.1 β3 adrenoceptor, pEC50: 5.9 | 99.96% |
Synephrine | | | ≥98.0% |
Higenamine | | | 98.91% |
Idazoxan hydrochloride | | | 99.32% |
Penbutolol sulfate | | | 98.72% |
Salbutamol hemisulfate | | | ≥98.0% |
CGP 20712 A | | | ≥99.0% |
Isoetharine mesylate | | | 99.87% |
Asenapine | Alpha-2A adrenergic receptor, pKi: 8.9 Alpha-2C adrenergic receptor, pKi: 8.9 α1-adrenergic receptor, pKi: 8.9 Alpha-2B adrenergic receptor, pKi: 9.5 | | 99.62% |
Midodrine hydrochloride | | | 99.49% |
Tamsulosin hydrochloride | | | 99.81% |
(R)-Propranolol hydrochloride | | | 99.36% |
Levobunolol hydrochloride | | | 99.89% |
Olodaterol hydrochloride | | β2 adrenoceptor, EC50: .1 nM | 98.87% |
Medetomidine | α2-adrenergic receptor, Ki: 1.08 nM α1-adrenergic receptor, Ki: 1750 nM | | 99.99% |
Zotepine | | | 99.85% |
BMY 7378 | rat α1A-adrenergic receptor, Ki: 800 nM hamster alpha1B-adrenergic receptor, Ki: 600 nM rat alpha1D-adrenergic receptor, Ki: 2 nM | | 99.92% |
Xamoterol hemifumarate | | | 99.92% |
Indoramin | | | 99.80% |
A-61603 | | | ≥99.0% |
Bufuralol hydrochloride | | | ≥99.0% |
NP10679 | Alpha-1A adrenergic receptor, IC50: 0.154 μM Alpha-1A adrenergic receptor, Ki: 0.603 μM Alpha-1B adrenergic receptor, Ki: 1.92 μM Alpha-1D adrenergic receptor, Ki: 0.495 μM Alpha-2C adrenergic receptor, Ki: 3.09 μM | | 99.42% |
Vatinoxan hydrochloride | | | 99.89% |
Practolol | | | 99.78% |
Denopamine | | | 98.67% |
Metaproterenol hemisulfate | | | 99.86% |
Clorprenaline hydrochloride | | | 99.90% |
Levalbuterol hydrochloride | | | 99.93% |
Desglymidodrine | α1A-adrenergic receptor, pKi: 5.89 α1B-adrenergic receptor, pKi: 5.16 rat alpha1D-adrenergic receptor, pKi: 5.78 human α2A-adrenoceptor, pKi: 5.83 | | |
Xylometazoline hydrochloride | Alpha-1A adrenergic receptor, Ki: 0.05 μM Alpha-1B adrenergic receptor, Ki: 0.30 μM Alpha-1D adrenergic receptor, Ki: 0.15 μM Alpha-2A adrenergic receptor, Ki: 0.88 μM Alpha-2B adrenergic receptor, Ki: 1.7 μM Alpha-2C adrenergic receptor, Ki: 0.19 μM | | 99.94% |
Norepinephrine tartrate | α1-adrenergic receptor α2-adrenergic receptor | Beta-1 adrenergic receptor | 99.76% |
ARC 239 dihydrochloride | Alpha-2B adrenergic receptor | | 99.57% |
(R)-(+)-Atenolol | | | ≥99.0% |
Ajmalicine | α1-adrenergic receptor α2-adrenergic receptor | | 99.39% |
BRL 37344 sodium | | | 99.90% |
Spiroxatrine | | | 99.18% |
Metoprolol-d7 hydrochloride | | | 99.71% |
Talinolol | | Beta-1 adrenergic receptor | 99.64% |
Efaroxan hydrochloride | | | 99.94% |
Ritodrine hydrochloride | | | 99.82% |
BMS-466442 | α adrenergic receptor, IC50: ≥10 μM | | 98.99% |
Bevantolol hydrochloride | | | 98.98% |
Synephrine hydrochloride | | | 99.66% |
Dapiprazole hydrochloride | | | 99.87% |
Tulobuterol | | | ≥98.0% |
Bisoprolol | | Beta-1 adrenergic receptor | 99.78% |
Clozapine (Standard) | | | 99.98% |
Amibegron hydrochloride | | | ≥99.0% |
Detomidine hydrochloride | | | 99.89% |
Metipranolol | | β1 adrenoceptor, pA2: 8.3 β2 adrenoceptor, pA2: 8.4 | 98.36% |
Urapidil hydrochloride | α1-adrenergic receptor, pIC50: 6.13 α2-adrenergic receptor, pIC50: 4.38 | | 99.97% |
Nifenalol hydrochloride | | | 99.93% |
Salmeterol-d3 | | | 98.91% |
Tasipimidine sulfate | human α2A-adrenoceptor, pEC50: 7.57 rodent α2D-adrenoceptor, pEC50: 6.56 human α2C-adrenoceptor, pEC50: 6.29 human α2B-adrenoceptor, pEC50: 6.00 | | 99.46% |
Zinterol hydrochloride | | | 99.51% |
Abanoquil | | | 98.43% |
Landiolol hydrochloride | | Beta-1 adrenergic receptor | 99.96% |
Ro 363 hydrochloride | | | |
Solabegron | | | 99.89% |
Clenproperol | | | 99.44% |
Midodrine | | | 99.67% |
(+)-Penbutolol | | | |
Alfuzosin hydrochloride | | | 99.82% |
Reproterol | | | |
Mabuterol | | Beta-2 adrenergic receptor | 99.96% |
BODIPY FL prazosin | α1A-adrenergic receptor, Ki: 14.5 nM α1B-adrenergic receptor, Ki: 43.3 nM | | 99.71% |
Melperone | α1-adrenergic receptor, Kd: 180 nM α2-adrenergic receptor, Kd: 150 nM | | 99.24% |
Dicentrine | | | 99.94% |
BMY-14802 hydrochloride | | | 98.02% |
Apraclonidine hydrochloride | | | 98.96% |
CGP 12177 hydrochloride | | Beta-1 adrenergic receptor Beta-2 adrenergic receptor Beta-3 adrenergic receptor | 99.69% |
Dopexamine hydrochloride | | | 99.71% |
Buflomedil hydrochloride | rat α1A-adrenergic receptor, Ki: 4.06 μM α1B-adrenergic receptor, Ki: 6.84 μM | | 99.81% |
Cyanopindolol | | | 98.67% |
MT-1207 | α1A-adrenergic receptor, IC50: 0.1 nM α1B-adrenergic receptor, IC50: 0.15 nM α1B-adrenergic receptor, Ki: 1.40 nM α1D-adrenergic receptor, IC50: 0.086 nM α1D-adrenergic receptor, Ki: 0.69 nM | | 99.96% |
Guanfacine | | | 99.85% |
ORM-10921 free base | Alpha-2C adrenergic receptor, Ki: 1.4 nM | | 98.08% |
Mibenratide | | Beta-1 adrenergic receptor | 99.77% |
Amidephrine | | | |
Scopine hydrochloride | | | 99.69% |
Metaterol | | | |
Methyldopate | | | 98.01% |
Butyryltimolol | | | ≥98.0% |
DL 071IT | | | 98.81% |
BMY 14802 | | | 98.96% |
Mirtazapine (Standard) | | | 99.95% |
Etoperidone | α1-adrenergic receptor, Kd: 38 nM α2-adrenergic receptor, Kd: 570 nM | | |
Celiprolol hydrochloride | | β adrenergic receptor, Ki: 0.14-8.3 μM | 98.93% |
Cimaterol | | | 99.13% |
(RS)-Butyryltimolol | | | ≥98.0% |
HOKU-81 | | Beta-2 adrenergic receptor | |
MK-761 free base | | Beta-2 adrenergic receptor | 99.56% |
Terazosin | | | |
Ecopipam hydrobromide | Alpha-2A adrenergic receptor, Ki: 731 nM | | ≥99.0% |
Brombuterol-d9 | | | ≥99.0% |
Clorprenaline | | | 99.33% |
Ulimorelin | | | |
Bunazosin | | | 98.52% |
Amosulalol | | Beta-1 adrenergic receptor | 98.69% |
α1A-AR Degrader 9c | α1A-adrenergic receptor, DC50: 2.86 μM | | |
Arformoterol tartrate | | Beta-2 adrenergic receptor, Kd: 2.9 nM | 99.63% |
Bupranolol | | | 98.73% |
Atenolol (Standard) | | Beta-1 adrenergic receptor | 99.94% |
(S)-Terazosin | | | 99.90% |
Xamoterol | | | |
α2A-AR agonist 1 | Alpha-2A adrenergic receptor, EC50: 0.23 nM Alpha-1A adrenergic receptor, EC50: 2.5 nM Alpha-2B adrenergic receptor, EC50: 16.3 nM Alpha-2C adrenergic receptor, EC50: 21.3 nM | | 99.92% |
Terbutaline (sulfate) (Standard) | | | 99.95% |
L-771688 | | | 99.46% |
ARC 239 | human α2C-adrenoceptor, pKi: 6.95 Alpha-2C adrenergic receptor, pKi: 7.06 | | 99.71% |
Midaglizole hydrochloride | | | 99.67% |
Zinterol | | | |
Prenalterol | | | 99.18% |
ST1936 | α1-adrenergic receptor, Ki: 390 nM (rat) α2-adrenergic receptor, Ki: 300 nM (rat) α2-adrenergic receptor, Ki: 300 nM (human) | | 99.70% |
Oxyfedrine | | | |
AGN 192836 | | | 99.49% |
(Rac)-Rotigotine hydrochloride | Alpha-2B adrenergic receptor | | 98.66% |
Xylometazoline | Alpha-1A adrenergic receptor, Ki: 0.05 μM Alpha-1B adrenergic receptor, Ki: 0.30 μM Alpha-1D adrenergic receptor, Ki: 0.15 μM Alpha-2A adrenergic receptor, Ki: 0.88 μM Alpha-2B adrenergic receptor, Ki: 1.7 μM Alpha-2C adrenergic receptor, Ki: 0.19 μM | | |
Mapenterol hydrochloride | | | 99.56% |
Isoetharine | | | |
Timolol hemihydrate | | | |
Blonanserin dihydrochloride | α2-adrenergic receptor, Ki: 530 nM α1-adrenergic receptor, Ki: 26.7 nM | | |
Timolol | | | |
(R,R)-Reboxetine mesylate | | | |
Sotalol | | | |
Dobutamine | | | |
Dobutamine tartrate | | | |
Ritodrine | | | |
Etoperidone hydrochloride | α1-adrenergic receptor, Kd: 38 nM α2-adrenergic receptor, Kd: 570 nM | | |
Metoprolol fumarate | | | |
Isamoltan hydrochloride | | β-adrenoceptor, IC50: 8.4 nM | |
Bopindolol fumarate | | β1 adrenoceptor β2 adrenoceptor β3 adrenoceptor | |
Trimazosin | | | |
Naftopidil dihydrochloride | Alpha-1A adrenergic receptor, Ki: 3.7 nM Alpha-1B adrenergic receptor, Ki: 20 nM Alpha-1D adrenergic receptor, Ki: 1.2 | | |
Flestolol sulfate | | | |
RS-79948-197 | rat α2A receptor, Kd: 0.42 nM rat α2B recepter, Kd: 0.18 nM rat α2C recepter, Kd: 0.19 nM human α2A-adrenoceptor, Kd: 0.6 nM human α2B-adrenoceptor, Kd: 0.46 nM human α2C-adrenoceptor, Kd: 0.77 nM | | |
Rezatomidine | | | |
Nipradolol | | | |
Piribedil dihydrochloride | | | |
Celiprolol | | β adrenergic receptor, Ki: 0.14-8.3 μM | |
Metoprolol-d6 tartrate | | | |
ent-Levobunolol hydrochloride | | | |
Zolertine hydrochloride | α1B-adrenergic receptor, pKi: 6.81 (in rat liver membrane) α1A-adrenergic receptor, pKi: 6.35 (in rabbit liver membrane) | | |
SB-206606 | | Beta-3 adrenergic receptor | |
α2AR agonist 1 | | | |
Oxprenolol | | β-adrenoceptor, Ki: 7.1 nM | |
Bopindolol | | β2 adrenoceptor Beta-1 adrenergic receptor Beta-3 adrenergic receptor | |
Nifenalol | | Beta-1 adrenergic receptor | |
Propranolol-d7 hydrochloride | | | 98.02% |
4-Hydroxypropranolol hydrochloride | | | |
Melperone hydrochloride | α1-adrenergic receptor, Kd: 180 nM α2-adrenergic receptor, Kd: 150 nM | | |
Fipamezole | human α2A-adrenoceptor, Ki: 9.2 nM human α2B-adrenoceptor, Ki: 17 nM human α2C-adrenoceptor, Ki: 55 nM | | |
(E)-Guanabenz | | | |
ST91 | | | 99.75% |
Fluparoxan | | | 99.66% |
α2C adrenoceptor agonist 1 | Alpha-2C adrenergic receptor, EC50: 108 nM Alpha-2C adrenergic receptor, Ki: 12 nM | | |
Rec 15/2615 hydrochloride | α1A-adrenergic receptor, Ki: 1.9 nM α1B-adrenergic receptor, Ki: 0.3 nM Alpha-1D adrenergic receptor, Ki: 2.6 nM | | |
Fenoterol (hydrobromide) (Standard) | | | |
Acebutolol-d7 | | | |
Isamoltane hemifumarate | | β-adrenoceptor, IC50: 8.4 nM | |
Isoprenaline hemisulfate | | | |
S(-)-Bisoprolol fumarate | | | |
Butaxamine | | | |
JP1302 | human α2C-adrenoceptor, Ki: 28±2 nM human α2B-adrenoceptor, Ki: 1470±130 nM human α2A-adrenoceptor, Ki: 3150±50 nM rodent α2D-adrenoceptor, Ki: 1700±200 nM | | |
LAS190792 | | β2 adrenoceptor, pIC50: 9.1 β3 adrenoceptor, pIC50: 5.6 β1 adrenoceptor, pIC50: 7.5 | |
Ajmalicine hydrochloride | α1-adrenergic receptor α2-adrenergic receptor | | |
S(-)-Bisoprolol | | | |
SM-2470 | | | |
Acebutolol | | | |
Bisoprolol fumarate | | Beta-1 adrenergic receptor | |
Procaterol | | | |
4-Hydroxypropranolol-d7 hydrochloride | | | |
β2AR/M3-receptor agonist-1 | | β2 adrenoceptor, pEC50: >9.2 | |
(±)-Penbutolol | | Beta-1 adrenergic receptor | |
RWJ52353 | Alpha-2D adrenergic receptor, Ki: 1.5 nM Alpha-2A adrenergic receptor, Ki: 254 nM α1-adrenergic receptor, Ki: 443 nM Alpha-2B adrenergic receptor, Ki: 621 nM | | |
Naftopidil hydrochloride | Alpha-1A adrenergic receptor, Ki: 3.7 nM Alpha-1B adrenergic receptor, Ki: 20 nM Alpha-1D adrenergic receptor, Ki: 1.2 nM | | |
Ecopipam | Alpha-2A adrenergic receptor, Ki: 731 nM | | |
Harmane (Standard) | | | |
Ro 70‐0004 | Alpha-1A adrenergic receptor, pKi: 8.9 | | |
Diacetolol-d7 | | | |
Meluadrine | | | |
Nemazoline | α1-adrenergic receptor α2-adrenergic receptor | | |
ST1936 oxalate | α1-adrenergic receptor, Ki: 390 nM (rat) α2-adrenergic receptor, Ki: 300 nM (rat) α2-adrenergic receptor, Ki: 300 nM (human) | | |
Meluadrine tartrate | | | |
(+)-Sotalol | | | 98.82% |
Cimbuterol-d9 | | | |
SUN-1334H free base | Alpha-1D adrenergic receptor, IC50: 7.76 μM | | |
Dapiprazole | | | |
Apraclonidine | | | |
CACPD2011a-0001278239 | | Beta-2 adrenergic receptor | |
Phenylethanolamine A-d3 | | | |
Moprolol | | Beta-1 adrenergic receptor | |
Pronethalol hydrochloride | | | |
N-5984 | | | |
Undecylenoyl phenylalanine | | | |
Asenapine citrate | Alpha-2A adrenergic receptor, pKi: 8.9 Alpha-2C adrenergic receptor, pKi: 8.9 α1-adrenergic receptor, pKi: 8.9 Alpha-2B adrenergic receptor, pKi: 9.5 | | |
Delequamine hydrochloride | α2-adrenergic receptor, pKi: 9.5 α1-adrenergic receptor, pKi: 5.3 | | |
Metaproterenol | | | |
Levalbuterol | | | |
Clenproperol-d7 | | | |
(±)-Penbutolol-d9 hydrochloride | | | |
L-665871 | | | |
Levobunolol | | | |
2-MPMDQ | α1-adrenergic receptor, Ki: 0.37 nM α2-adrenergic receptor, Ki: 1740 nM | | |
Sulfinalol | | | |
Mabuterol-d9 | | | |
Pafenolol | | Beta-1 adrenergic receptor | |
Agroclavine | | | |
Landiolol | | Beta-1 adrenergic receptor | |
Clozapine dihydrochloride | α2-adrenergic receptor, Ki: 51 nM | | |
Bunitrolol | | | |
TD-5471 hydrochloride | | | |
SAR-150640 | | | |
Buflomedil | rat α1A-adrenergic receptor, Ki: 4.06 μM α1B-adrenergic receptor, Ki: 6.84 μM | | |
Methyldopate hydrochloride | | | |
AVN-101 hydrochloride | Alpha-1D adrenergic receptor, Ki: 30.2 nM Alpha-1B adrenergic receptor, Ki: 9.4 nM Alpha-2A adrenergic receptor, Ki: 1.77 nM Alpha-2C adrenergic receptor, Ki: 3.55 nM Alpha-1A adrenergic receptor, Ki: 18.9 nM Alpha-2B adrenergic receptor, Ki: 0.41 nM | | 99.59% |
LY 344864 hydrochloride | rat α1-adrenergic receptor, Ki: 5.06 μM rat α2-adrenergic receptor, Ki: 3.69 μM | | |
AH 11110A | | | |
Platelet aggregation-IN-3 | | | |
Ractopamine | | pig β1AR, Kd: ~25 nM pig β2AR, Kd: ~25 nM | |
β2AR agonist /M-receptor antagonist-1 | | Beta-2 adrenergic receptor | |
Brombuterol-d9 hydrochloride | | | |
CHF-6550 | | β2 adrenoceptor, pKi: 10.6 | |
Metrenperone | α1-adrenergic receptor α2-adrenergic receptor | | |
Zilpaterol-d7 | | | |
Bevantolol | | Beta-1 adrenergic receptor | |
Doxazosin-d8 | | | |
TAAR1 agonist 3 | Alpha-2A adrenergic receptor, pEC50: 6 | | |
Levobetaxolol | | β1 adrenoceptor, IC50: 33.2 nM β2 adrenoceptor, IC50: 2970 nM β3 adrenoceptor, IC50: 709 nM | |
Todralazine | | | |
CL 316243 free acid | | | 99.37% |
Arformoterol maleate | | Beta-2 adrenergic receptor, Kd: 2.9 nM | |
A 80426 mesylate | | | |
Levalbuterol tartrate | | | |
Landiolol hydrochloride (Standard) | | Beta-1 adrenergic receptor | |
Iloperidone carboxylic acid | human α2C-adrenoceptor, pKi: 7.32 human α2A-adrenoceptor, pKi: 6.42 rat α1-adrenergic receptor, pKi: 7.67 human α2B-adrenoceptor, pKi: 7.08 | | |
Indacaterol xinafoate | | | |
Mabuterol hydrochloride | | Beta-2 adrenergic receptor | |
Fiduxosin hydrochloride | α1A-adrenergic receptor, IC50: 0.16 nM α1B-adrenergic receptor, IC50: 24.9 nM α1D-adrenergic receptor, IC50: 0.92 nM | | |
Bunitrolol hydrochloride | | | |
PF-9404C | | | |
Melperone (Standard) | α1-adrenergic receptor, Kd: 180 nM α2-adrenergic receptor, Kd: 150 nM | | |
Sulfinalol hydrochloride | | | |
Melperone-d4 hydrochloride | α1-adrenergic receptor, Kd: 180 nM α2-adrenergic receptor, Kd: 150 nM | | 99.84% |
SB251023 | | Beta-3 adrenergic receptor | |
Protokylol hydrochloride | | Beta-2 adrenergic receptor | |
Methyldopa hydrochloride | | | |
Cafedrine-theodrenaline | | | |
CHIR-2279 | α1-adrenergic receptor, Ki: 5 nM | | |
RU 52583 | | | |
Salbutamol adipate | | | |
Org 6906 | α2-adrenergic receptor, pKi: 6.5 | | |
Harmane hydrochloride | α2-adrenergic receptor, IC50: 18 μM | | |
Carbuterol hydrochloride | | Beta-2 adrenergic receptor | |
Clorprenaline-d7 | | | |
R 47 243 | | | |
Esmolol | | | |
L-748328 | | β3 adrenoceptor, Ki: 3.7 nM | |
(rac)-Nebivolol-d4 | | | |
Cicloprolol hydrochloride | | | |
Pargolol hydrochloride | | | |
OPC-28326 | | | |
Ko-3290 | | | |
Delequamine | α2-adrenergic receptor, pKi: 9.5 α1-adrenergic receptor, pKi: 5.3 | | |
L-770644 | | Beta-3 adrenergic receptor, EC50: 13 nM | |
Azepexole dihydrochloride | | | |
Tasipimidine | Alpha-2A adrenergic receptor | | |
Buflomedil (hydrochloride) (Standard) | rat α1A-adrenergic receptor, Ki: 4.06 μM α1B-adrenergic receptor, Ki: 6.84 μM | | |
Clozapine hydrochloride | α2-adrenergic receptor, Ki: 51 nM | | |
Ridazolol | | Beta-1 adrenergic receptor | |
Trimazosin hydrochloride hydrate | | | |
α1 adrenoceptor-MO-1 | | | |
Epanolol | | | |
Benzquinamide | | | |
Fenmetozole Tosylate | | | |
AR-08 | | | |